119 related articles for article (PubMed ID: 2732458)
1. Heterogeneic expression of blood group A and H isoantigens in bladder tumors: association with nuclear volume.
Orntoft TF; Nielsen K
J Histochem Cytochem; 1989 Jul; 37(7):1153-5. PubMed ID: 2732458
[TBL] [Abstract][Full Text] [Related]
2. [The study of the ABH isoantigen of bladder tumors].
Fukatsu H; Nonomura H; Miyagawa Y; Waki M; Hatano Y; Hiraiwa S; Muramatsu T; Takamura T; Yamada Y; Nishikawa E
Hinyokika Kiyo; 1987 Jun; 33(6):857-63. PubMed ID: 3314420
[TBL] [Abstract][Full Text] [Related]
3. Blood group isoantigens ABO (H) in transitional carcinoma of the bladder: a clinicopathological study.
Cuadrado E; Rodriguez-Trinidad A; Blasco E; Torrado J; Lopez Garcia JA; Arozena F
J Urol; 1986 Feb; 135(2):409-15. PubMed ID: 3511295
[TBL] [Abstract][Full Text] [Related]
4. Double blind comparison of T-antigen and ABO(H) cell surface antigens in bladder cancer.
Vafier JA; Javadpour N; Worsham GF; O'Connell KJ
Urology; 1984 Apr; 23(4):348-51. PubMed ID: 6369713
[TBL] [Abstract][Full Text] [Related]
5. [Studies on blood group isoantigens in uroepithelium. I. Determination of isoantigens in non-malignant epithelium of tumor-bearing bladder].
Abe R
Nihon Hinyokika Gakkai Zasshi; 1985 Jul; 76(7):1049-58. PubMed ID: 4079195
[No Abstract] [Full Text] [Related]
6. [Isoantigens ABH in bladder tumors as an indicator of malignant potential. III. Detection by PAP method and a classification of staining pattern].
Nasu Y; Kumon H; Matsumura Y; Ohmori H
Nihon Hinyokika Gakkai Zasshi; 1984 May; 75(5):739-43. PubMed ID: 6208400
[No Abstract] [Full Text] [Related]
7. [Isoantigens ABH in bladder tumors as an indicator of malignant potential. II. Results of a long-term follow-up and technical problems].
Kumon H; Nasu Y; Matsumura Y; Ohmori H
Nihon Hinyokika Gakkai Zasshi; 1984 May; 75(5):731-8. PubMed ID: 6492527
[No Abstract] [Full Text] [Related]
8. Detection of blood group surface antigens of urinary bladder tumours using monoclonal antibodies with the avidin-biotin complex technique.
Tan LB; Chiang C; Huang CH; Lin LM
Int Urol Nephrol; 1992; 24(3):255-64. PubMed ID: 1399382
[TBL] [Abstract][Full Text] [Related]
9. A modified immunoperoxidase method for the detection of ABH tissue isoantigens in patients with bladder carcinoma.
Stul MS; Logghe GN; Bergmans GB; Vanvuchelen JK
Exp Pathol; 1985; 27(2):119-22. PubMed ID: 3888650
[TBL] [Abstract][Full Text] [Related]
10. Monoclonal antibodies to detect A, B and H blood group isoantigens in superficial transitional cell carcinoma of the bladder: a means of predicting invasive recurrences.
Stephenson TJ; Williams JL; Gelsthorpe K
Br J Urol; 1985 Apr; 57(2):148-53. PubMed ID: 3886066
[TBL] [Abstract][Full Text] [Related]
11. Immunoperoxidase detection of carcinoembryonic antigen and blood group substances in papillary transitional cell carcinoma of the bladder.
Wiley EL; Mendelsohn G; Droller MJ; Eggleston JC
J Urol; 1982 Aug; 128(2):276-80. PubMed ID: 7050419
[TBL] [Abstract][Full Text] [Related]
12. [Correlation of the expression of A, B isoantigens with its precursor H antigen in transitional cell carcinoma and the clinical signification of the expression].
Yang SC
Zhonghua Wai Ke Za Zhi; 1990 Oct; 28(10):631-3, 639. PubMed ID: 2086062
[TBL] [Abstract][Full Text] [Related]
13. Blood group H antigen in transitional carcinoma of the urinary bladder.
Tichý M; Tichá V; Jansa P; Student V; Vanák J
Acta Univ Palacki Olomuc Fac Med; 1991; 130():157-62. PubMed ID: 1838863
[TBL] [Abstract][Full Text] [Related]
14. [Immunohistochemical demonstration of carcinoembryonic antigen (CEA) and ABO (H) blood group antigens on tissue sections of urinary bladder tumors].
Fujioka T; Tanji S; Koike H; Kubo T; Ohhori T
Hinyokika Kiyo; 1985 Oct; 31(10):1709-16. PubMed ID: 3911765
[TBL] [Abstract][Full Text] [Related]
15. [Studies on multiple mucosal biopsy in patients with bladder cancer. 4. Evaluation of Thomsen-Friedenreich antigen in multiple mucosal biopsy and transitional cell carcinoma of the bladder].
Igawa M
Hinyokika Kiyo; 1986 Nov; 32(11):1663-76. PubMed ID: 3825815
[TBL] [Abstract][Full Text] [Related]
16. [Isoantigens ABH in bladder tumors as an indicator of malignant potential. IV. Correlation with Thomsen-Friedenreich antigen and CEA].
Nasu Y; Kumon H; Matsumura Y; Ohmori H
Nihon Hinyokika Gakkai Zasshi; 1986 Sep; 77(9):1511-8. PubMed ID: 3807094
[No Abstract] [Full Text] [Related]
17. The prediction of invasive potential in superficial transitional cell carcinoma of the bladder.
Finan PJ; Anderson JR; Doyle PT; Lennox ES; Bleehen NM
Br J Urol; 1982 Dec; 54(6):720-5. PubMed ID: 6758916
[TBL] [Abstract][Full Text] [Related]
18. Investigation of ABH antigenicity of random mucosal biopsies and transitional cell carcinoma of the urinary bladder.
Jakse G; Hofstädter F
Eur Urol; 1983; 9(2):97-101. PubMed ID: 6852091
[TBL] [Abstract][Full Text] [Related]
19. Visualization of urothelial blood group isoantigens A and B using direct biotin-labeled antibodies and avidin-biotin-peroxidase complex.
Lin CW; Fujime M; Kirley SD; Prout GR
J Histochem Cytochem; 1984 Dec; 32(12):1139-43. PubMed ID: 6209329
[TBL] [Abstract][Full Text] [Related]
20. A, B, O (H) antigenic determinants in superficial transitional cell tumors of bladder.
Selli C; Cozzolino F; Vercelli D; Mincione GP
Urology; 1983 Feb; 21(2):132-4. PubMed ID: 6186066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
